{"product_id":"ppar-agonists-as-novel-therapeutic-target-in-alzheimers-disease-von-jalaram-thakkar","title":"PPAR¿ Agonists: As Novel Therapeutic Target in Alzheimer's Disease","description":"\u003cp\u003eAlzheimer¿s disease is the most common form of neurodegenerative disorder with dementia. The Alzhemer's disease brain pathology is characterized by deposits of amyloid-¿ (A¿) peptides and neurofibrillary tangles but also (among other aspects) by signs of a chronic inflammatory process.Epidemiological studies have shown that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk of developing AD and delays its onset. Classical targets of NSAIDs include cycloxygenase, nuclear factor ¿B, and peroxisome proliferator-activated receptors.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9783330059559\"\u003e\u003ch3\u003e\u003c\/h3\u003e\u003c\/div\u003e","brand":"Libri","offers":[{"title":"Softcover - 9783330059559","offer_id":39426890334301,"sku":"9783330059559","price":35.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/59c578b2-c48a-4a18-ab5b-8240c83f5d5c.jpg?v=1770098779","url":"https:\/\/shop.autorenwelt.de\/products\/ppar-agonists-as-novel-therapeutic-target-in-alzheimers-disease-von-jalaram-thakkar","provider":"Autorenwelt Shop","version":"1.0","type":"link"}